Regenxbio RGNX Market capitalization

Market capitalization at other companies

Regeneron PharmaceuticalsREGN

$65.37B+15.9%

Sarepta Therapeutics, Inc.SRPT

$1.9B+1.7%

BiogenBIIB

$31.9B+72.4%

BioMarin PharmaceuticalsBMRN

$11.06B+5.4%

EyePoint, Inc.EYPT

$1.2B+89.8%

Ultragenyx PharmaceuticalRARE

$3.29B-6.4%

FAQ

What is Regenxbio's market capitalization?

Regenxbio (RGNX) reported market capitalization of $619.34M in Q2 2026.

How has Regenxbio's market capitalization changed year-over-year?

Regenxbio's market capitalization increased by 43.6% year-over-year, from $431.33M to $619.34M.

What is the long-term trend for Regenxbio's market capitalization?

Over 5 years (2020 to 2025), Regenxbio's market capitalization has grown at a -17.8% compound annual growth rate (CAGR), from $1.94B to $728.97M.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.